The Indian Pharmacopoeia Commission (IPC) and the US Pharmacopeial Convention (USP) Tuesday signed a memorandum of understanding (MoU) to promote greater awareness about quality and safety of medicines.
A pharmacopoeia pertains to compilation of technical information on standards for active pharmaceutical ingredients, drug products and associated testing techniques for evaluation and quality of these products.
"Greater co-ordination and complementarity in the activities of the two pharmacopoeias would promote the interests of patients in both countries," said Prasanna Hota, chairman of IPC and secretary in the health and family welfare ministry.
Hota signed the MoU along with Roger L. Williams, executive vice president and head of USP.
Stating keenness to expand ongoing cooperation with IPC, Williams said greater collaborative work would help to "reach the overarching goal of providing 'Good Pharmaceutical Care for All'".
USP established its first site overseas in September last year with the incorporation of US Pharmacopeia-India Private Ltd., located in the ICICI Knowledge Park at Shameerpet in Hyderabad.
This was followed by the formal inauguration of its state-of-the-art office and laboratory at ICICI Knowledge Park in February this year. The laboratory involves experienced Indian scientists in the standards-setting activities of USP.